Introduction
The re-uptake of neurotransmitters from the synaptic cleft by high-affinity transport appears to play an important role in the overall process of synaptic transmission [l, 21 . The process is catalysed by sodium-coupled neurotransmitter transport systems (reviewed in located in plasma membranes of nerve endings and glial cells. These transport systems have been investigated in detail by using plasma membranes obtained upon osmotic shock of synaptosomes. It appears that these transporters are coupled not only to sodium, but also to additional ions like potassium or chloride.
L-Glutamate is considered to be the major excitatory transmitter in brain, and aspartate may have a similar action [6-81. Its re-uptake system is held to be the mechanism by which synaptically released excitatory amino acids are inactivated [9] and kept below toxic levels in the extracellular space [lo] . The system appears to catalyse electrogenic cotransport of sodium and L-glutamate while potassium is translocated in the opposite direction [ 11 -141. Three sodium ions are translocated with one glutamate anion, and one potassium ion is countertransported [ 11, 151. 
Mechanistic studies
Membrane vesicles from rat brain exhibit sodiumdependent uptake of [3H]~,-glutamate in the absence of any transmembrane ion gradients. The substrate specificity of the process is identical with
Although these vesicles are prepared after osmotic shock and are washed repeatedly, they contain about 1.5 nmol/mg of endogenous L-glutamate, apparently located inside the vesicles. The affinity of the process ( K , -1 pM) is similar to that of (Na+ + K+)-dependent accumulation by the Lglutamate transporter. Membrane vesicles have been disrupted by the detergent cholate, and the solubilized proteins have subsequently been reconstituted into liposomes. The reconstituted proteoliposomes also exhibit the above uptake -with the Abbreviation used: GABA, y-aminobutyric acid.
same characteristics -provided they contain entrapped cold L-glutamate. Counterflow is optimal when sodium is present on both sides of the membrane, but partial activity is still observed when sodium is present either on the inside or on the outside. Increasing the L-glutamate concentration above the K , results in counterflow completely independent of cis-sodium. The initial rate of counterflow is 100-200-fold lower than that of net trans-potassium-dependent flux. The rate of net flux in the presence of trans-sodium or lithium is about 10-fold lower than when choline or Tris are used instead. However, the rate of counterflow (no internal potassium present) was not stimulated by replacing internal sodium or lithium by internal choline. Therefore, optimal functioning of the transporter requires internal potassium while internal sodium and lithium are inhibitory. In addition, the membrane vesicles also contain a low-affinity uptake system ( K , -100 pM) for L-glutamate, which is also dependent on &-sodium and transpotassium. The above data are accommodated in a refined model of the translocation cycle of the
Purification and reconstitution of the transporter
The sodium-and potassium-coupled L-glutamate transporter from rat brain has been purified to near homogeneity by reconstitution of transport as an assay, assuming that inactivated and active transporters co-chromatograph. The purification steps involve lectin chromatography of the membrane proteins solubilized with 3-[(3-~holamidopropyl)-dimethylammonio]-1 -propanesulphonate (CHAPS), fractionation on hydroxylapatite and ion-exchange chromatography. The specific activity is increased 30-fold. The actual purification is higher since three-five-fold inactivation occurs during the purification. The efficiency of reconstitution was about 20%. The properties of the pure transporter are fully preserved. They include ion dependence, electrogenicity, affinity, substrate specificity and stereospecificity. SDS/PAGE revealed one main band with an apparent molecular mass of around Polyclonal antibodies were generated against the major polypeptide (73 kDa) present in a highly purified preparation of the (Na+ + K+)-coupled Lglutamate transporter from rat brain. These antibodies were able to selectively immunoprecipitate the 73 kDa polypeptide as well as most of the I,-glutamate transport activity -as assayed upon reconstitution -from crude detergent extracts of rat brain members. The immunoreactivity in the various fractions obtained during the purification procedure [ 181 closely correlated with the L-glutamate transport activity. Immunoblotting of a crude SDS brain extract, separated by two-dimensional isoelectric focusing-SDS/PAGE, showed that the antibodies recognized one 73 kDa protein species only with an apparent isoelectric point of about pH 6.2. Deglycosylation of the protein gave a 10 kDa reduction in molecular mass, but no reduction in immunoreactivity. These findings establish that the 73 kDa polypeptide represents the L-glutamate transporter or a subunit thereof. The antibodies also recognize a 73 kDa polypeptide and immunoprecipitate 1,-glutamate transport activity in extracts of brain plasma membranes from rabbit, cat and man [191. lmmunocytochemistry Using the antibodies raised against the glutamate transporter, the immunocytochemical localization of the transporter was studied at the light and electron microscopic levels in rat central nervous system. In all regions examined (including cerebral cortex, caudato-putamen, corpus callosum, hippocampus, cerebellum and spinal cord) it was found to be located in glial cells rather than in neurons. In particular, fine astrocytic processes were strongly stained. Putative glutamatergic axon terminals appeared non-immunoreactive. The uptake of glutamate by such terminals (for which there is strong previous evidence) may therefore be due to a subtype of glutamate transporter different from the glial transporter demonstrated by our group [ 191. Using a monoclonal antibody raised against the transporter, a similar glial localization of the transporter was found [20] .
Molecular cloning
Using an antibody against the glial L-glutamate transporter from rat brain, we have isolated a complementary DNA clone (pT7-GLT-1) encoding this transporter. Expression of pT7-GLT-1 in transfected HeLa cells indicates that L-glutamate accumulation requires external sodium and internal potassium and exhibits the expected stereospecificity. The cDNA sequence predicts a protein of 573 amino acids with eight-nine putative transmembrane a-helices. Database searches indicate that this protein is not homologous to any identified protein of mammalian origin, including the recently described superfamily of neurotransimtter transporters. Therefore, GLT-1 appears to be a member of a previously uncharacterized family of transport molecules [21] . The extraordinary diversity in how neurons and glia cells respond to signals from the environment and the surrounding cells is crucial for many aspects of development, survival and plasticity responses in the mammalian nervous systems. Several proposals emphasize that this phenotypic diversity and functional complexity may depend on co-ordinated changes in gene expression [ 1-31. An intriguing question to address is how cell-specific, conserved genetic programmes may change throughout development or in mature cells, underlying long-term adaptive changes in the nervous system operative in neuronal plasticity, information storage or sprouting. The regulation of eukaryotic gene transcription appears to be mediated by specific DNA-binding proteins which interact with short sequence motifs located in a specific array on the promoter region of the genes. Many of these regulatory factors function as 'nuclear third messengers' in the nervous system; they are regulated by signals triggered by various extracellular stimuli (e.g. specific transmitter receptor stimulation, hormones, ions) and interact directly or indirectly with the transcriptional machinery of the cell, thereby targeting the information to the genome (Figure 1) . Interestingly, up to now, a relatively small number of distinct families of DNA-binding proteins has been identified [4] . Therefore, the precision and flexibility required for the orchestration of multiple target gene expression should rely on the complex regulation and interaction of these transcription factors. [6] or bringing about direct control of target gene expression [7] . On the other hand, ligand-dependent nuclear receptors (steroid/thyroid receptor superfamily) directly link hormonal stimuli to transcription control [8] .
Second, multi-protein families of transcriptional factors exist with related DNA-binding specificities, typified by the fos and jun gene families providing various activating protein (AP)-1 complexes, cyclic AMP response element binding (CREB)/activating transcription factor (ATF) proteins or the steroid/ thyroid receptors [9-111. These factors are able to form and to bind to DNA as homo-and heterodimers, thereby clearly enabling a relatively small number of factors to generate a large diversity of transcriptional complexes. This diversity, which may depend partly on the temporal pattern and relative extent of the expression of these factors following stimulation, is expanded further by factorspecific post-translational modifications (eg. phosphorylation, glycosylation). In addition, protein-protein interaction between distinct classes of third messengers and cell-specific factors may provide further specificity in positive and negative regulation of gene expression. Third, recent evidence has revealed that further transcriptional activators/repressors, encoded by the same gene, can be generated by alternative splicing or alterna-
